Additionally, the activation of the complement factors C3a and C5a can further stimulate mast cell degranulation, contributing to inflammatory processes and potentially worsening CSU symptoms in patients with autoimmune thyroid diseases [15,26]. Here, C3 is linked to autoimmune thyroid disease.